Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

120
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
120
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

83
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
83
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

180
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
180
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

114
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
114
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

134
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
134
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

213
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
213

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the study carried out by ANSES on the effectiveness of sanitary shucking of queen scallops (<i>Aequipecten opercularis</i>) contaminated by okadaic acid toxins.

EFSA journal. European Food Safety Authority·2026
Same author

Avian Influenza annual report 2024.

EFSA journal. European Food Safety Authority·2025
Same author

Letter to the Editor: Critical analysis of "The use of canonical dose-response models for benchmark dose analysis of continuous toxicological data" by Slob et al. (2025).

Critical reviews in toxicology·2025
Same author

Derivation of a health-based guidance value for Δ<sup>8</sup>-tetrahydrocannabinol (Δ<sup>8</sup>-THC) and its occurrence in food.

EFSA journal. European Food Safety Authority·2025
Same authorSame journal

A hierarchical constrained density regression model for predicting cluster-level dose-response.

Environmetrics·2025
Same author

Re-evaluation of neotame (E 961) as food additive.

EFSA journal. European Food Safety Authority·2025
Same journal

Bayesian Inference for Spatially-Temporally Misaligned Data Using Predictive Stacking.

Environmetrics·2026
Same journal

Spike and Slab Regression for Nonstationary Gaussian Linear Mixed Effects Modeling of Rapid Disease Progression.

Environmetrics·2026
Same journal

Semiparametric approaches for mitigating spatial confounding in large environmental epidemiology cohort studies.

Environmetrics·2025
Same journal

Penalized distributed lag interaction model: Air pollution, birth weight, and neighborhood vulnerability.

Environmetrics·2025
Same journal

Assessing predictability of environmental time series with statistical and machine learning models.

Environmetrics·2025
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K

An extended and unified modeling framework for benchmark dose estimation for both continuous and binary data.

Marc Aerts1, Matthew W Wheeler2, José Cortiñas Abrahantes3

  • 1Data Science Institute, Interuniversity Institute for Biostatistics and statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium.

Environmetrics
|September 2, 2022
PubMed
Summary
This summary is machine-generated.

Model averaging offers an advanced benchmark dose approach for health guidance values. This study proposes a unified framework for dose-response models, improving benchmark dose estimation for continuous and binary endpoints.

Keywords:
Akaike information criterionbenchmark dosebootstrapcumulative distribution functiondose responsemaximum likelihoodmodel averaging

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K
Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities

Published on: February 20, 2021

5.1K

Related Experiment Videos

Last Updated: Aug 30, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K
Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities

Published on: February 20, 2021

5.1K

Area of Science:

  • Toxicology
  • Biostatistics
  • Pharmacometrics

Background:

  • Protection and safety authorities advocate for model averaging in benchmark dose (BMD) approach.
  • The BMD approach is considered scientifically advanced for deriving health-based guidance values compared to the no-observed-adverse-effect-level (NOAEL) approach.
  • Current model averaging practices for continuous endpoints use limited models (e.g., exponential, Hill), unlike the richer sets for binary endpoints.

Purpose of the Study:

  • To propose a general and comprehensive framework of dose-response models applicable to both continuous and binary endpoints.
  • To provide a unified approach to benchmark dose estimation by integrating this framework with bootstrap methods.
  • To expand the repertoire of models used in benchmark dose determination for improved accuracy and reliability.

Main Methods:

  • Development of a generalized framework encompassing a wide range of dose-response models.
  • Application of the bootstrap method in conjunction with the proposed model framework.
  • Illustration of the methodology using empirical data sets with both continuous and binary endpoints.

Main Results:

  • The proposed framework successfully integrates existing models for both continuous and binary endpoints.
  • The unified approach using the generalized framework and bootstrap demonstrates effective benchmark dose estimation.
  • The methodology is validated through practical application on diverse datasets.

Conclusions:

  • The proposed generalized framework offers a unified and robust approach to benchmark dose estimation.
  • This methodology enhances the scientific rigor of deriving health-based guidance values.
  • The framework's applicability to both continuous and binary endpoints represents a significant advancement in toxicological risk assessment.